Z-1237-2019 Class II Ongoing
FDA device recall Z-1237-2019 was initiated by PerkinElmer Life And Analytical Sciences, Wallac, OY on Jan 10, 2019 and is designated Class II. Reason for recall: hCG analyte concentrations may be decreased up to 15- 20% at the lower measuring range of hCG concentrations. The recall status is ongoing. Affected quantity: 31 kits (10 in US, 21 in ROW).
Recall details
- Product Type
- Devices
- Report Date
- May 8, 2019
- Initiation Date
- Jan 10, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31 kits (10 in US, 21 in ROW)
Product description
DELFIA¿ hCG Kit, In Vitro Diagnostic for the determination of human gonadotropin (hCG) Product Code: A007-101 - Product Usage: Quantitative determination of human gonadotrophin (hCG) in serum.
Reason for recall
hCG analyte concentrations may be decreased up to 15- 20% at the lower measuring range of hCG concentrations.
Distribution pattern
Worldwide distribution - US Nationwide distribution. and countries of Austria, Bolivia, UK, Switzerland,Thailand, Finland.
Code information
Kit Lot Numbers: 664891, 666471, 666604 Pack Lot Numbers: 1066489101, 1066647101,1066660401 UDI: (01)06438147009176(17)190430(10)664891 (01)06438147009176(17)190430(10)666471 (01)06438147009176(17)190430(10)666604
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1237-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026